Breaking News

Bristol Myers Squibb Invests in Cell Therapy Ops

New manufacturing site planned in the Netherlands is the company’s fifth facility dedicated to cell therapy.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Bristol Myers Squibb has selected Leiden, Netherlands to house a new cell therapy manufacturing site in Europe, leveraging the growing life sciences region near Amsterdam and convenient access to transportation for shipping patient cells.   As part of Bristol Myers Squibb’s continuing commitment to patients with aggressive hematological cancers and its growing cell therapy franchise, the company is making this significant new investment to expand global manufacturing capacity and bring treatme...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters